Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9444 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9444 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9444 |
High Similarity |
NPD6166 |
Phase 2 |
0.9048 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.9006 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8827 |
High Similarity |
NPD1934 |
Approved |
0.8824 |
High Similarity |
NPD6797 |
Phase 2 |
0.8795 |
High Similarity |
NPD6959 |
Discontinued |
0.878 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8772 |
High Similarity |
NPD7251 |
Discontinued |
0.8765 |
High Similarity |
NPD7074 |
Phase 3 |
0.8706 |
High Similarity |
NPD7054 |
Approved |
0.8704 |
High Similarity |
NPD4380 |
Phase 2 |
0.8655 |
High Similarity |
NPD7472 |
Approved |
0.8623 |
High Similarity |
NPD5494 |
Approved |
0.8613 |
High Similarity |
NPD7808 |
Phase 3 |
0.8613 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8606 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8596 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD1512 |
Approved |
0.8554 |
High Similarity |
NPD3882 |
Suspended |
0.8545 |
High Similarity |
NPD2801 |
Approved |
0.8538 |
High Similarity |
NPD3818 |
Discontinued |
0.8503 |
High Similarity |
NPD7075 |
Discontinued |
0.8447 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8395 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8393 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8372 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8314 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8304 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8276 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8263 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8249 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8249 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8204 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8187 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8166 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8137 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8107 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8107 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8034 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8033 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8022 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7989 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7964 |
Intermediate Similarity |
NPD5403 |
Approved |
0.791 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7861 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7844 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7841 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7824 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7812 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7809 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7791 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7791 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.776 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7737 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7727 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7717 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7702 |
Intermediate Similarity |
NPD943 |
Approved |
0.7692 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD6190 |
Approved |
0.764 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7617 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7617 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7617 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7617 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7614 |
Intermediate Similarity |
NPD919 |
Approved |
0.7614 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7579 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7577 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7577 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7545 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7529 |
Intermediate Similarity |
NPD37 |
Approved |
0.7529 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7515 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3750 |
Approved |
0.75 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4965 |
Approved |
0.75 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4966 |
Approved |
0.75 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7485 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7461 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7453 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7448 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7437 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7437 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7437 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7433 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7398 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7398 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7396 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7387 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7387 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7382 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7382 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7351 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7333 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7305 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7262 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7262 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD920 |
Approved |
0.7225 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7202 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7198 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7189 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7168 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD5405 |
Approved |
0.716 |
Intermediate Similarity |
NPD5406 |
Approved |
0.716 |
Intermediate Similarity |
NPD5408 |
Approved |
0.716 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.715 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7125 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7104 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7104 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7093 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7085 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7062 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7062 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7056 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7035 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7027 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7024 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7024 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7019 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7018 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7 |
Intermediate Similarity |
NPD4002 |
Approved |
0.6995 |
Remote Similarity |
NPD4287 |
Approved |
0.6994 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6994 |
Remote Similarity |
NPD7003 |
Approved |
0.699 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD6273 |
Approved |
0.6985 |
Remote Similarity |
NPD3450 |
Approved |
0.6985 |
Remote Similarity |
NPD2493 |
Approved |
0.6985 |
Remote Similarity |
NPD2494 |
Approved |
0.6985 |
Remote Similarity |
NPD3452 |
Approved |
0.6977 |
Remote Similarity |
NPD2424 |
Discontinued |
0.697
|
Remote Similarity |
NPD9494 |
Approved |